We are live on ! Find out more
SCM

Suvretta Capital Management Portfolio holdings

AUM $3.92B
1-Year Est. Return 86.67%
This Fund
S&P 500
This Quarter Est. Return
+12.88%
1 Year Est. Return
+86.67%
3 Year Est. Return
+295.96%
5 Year Est. Return
+364.48%
10 Year Est. Return
+2,073.65%
AUM
$3.32B
AUM Growth
+$622M
Cap. Flow
+$387M
Cap. Flow %
11.66%
Top 10 Hldgs %
45.52%
Holding
112
New
12
Increased
30
Reduced
18
Closed
14

Top Buys

Rank Stock Value
1
KO icon
Coca-Cola
KO
+$58.2M
2
DKS icon
Dick's Sporting Goods
DKS
+$48.3M
3
GEHC icon
GE HealthCare
GEHC
+$37.1M
4
DHR icon
Danaher
DHR
+$31.2M
5
GE icon
GE Aerospace
GE
+$24M

Sector Composition

Rank Sector Weight
1 Healthcare 48.97%
2 Technology 9.89%
3 Consumer Discretionary 5.64%
4 Financials 4.91%
5 Communication Services 4.24%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
MCK icon
76
McKesson
MCK
$101B
$1.34M 0.04%
1,830
WING icon
77
Wingstop
WING
$3.18B
$1.33M 0.04%
+3,961
New +$1.17M
HCA icon
78
HCA Healthcare
HCA
$89.5B
$1.22M 0.04%
3,190
IQV icon
79
IQVIA
IQV
$39.3B
$1.13M 0.03%
7,175
WAT icon
80
Waters Corp
WAT
$39.9B
$1.1M 0.03%
3,150
LKFT
81
Lakefront Biotherapeutics American Depositary Shares
LKFT
$1.77B
$1.04M 0.03%
37,111
AVTR icon
82
Avantor
AVTR
$9.19B
$967K 0.03%
71,850
OS
83
DELISTED
OneStream Inc
OS
$936K 0.03%
+33,080
New +$824K
EW icon
84
Edwards Lifesciences
EW
$51.7B
$868K 0.03%
11,100
UAL icon
85
United Airlines
UAL
$42.1B
$828K 0.03%
10,401
-355,974
-97% -$26.2M
CRH icon
86
CRH
CRH
$66.8B
$777K 0.02%
8,460
-5,590
-40% -$510K
RMD icon
87
ResMed
RMD
$30.7B
$617K 0.02%
2,390
A icon
88
Agilent Technologies
A
$41.2B
$589K 0.02%
4,990
VLTO icon
89
Veralto
VLTO
$24B
$553K 0.02%
5,475
CZR icon
90
Caesars Entertainment
CZR
$6.14B
$536K 0.02%
18,875
-633,618
-97% -$17.2M
IONS icon
91
Ionis Pharmaceuticals
IONS
$9.4B
$427K 0.01%
10,800
STE icon
92
Steris
STE
$23.1B
$368K 0.01%
1,530
PEPG icon
93
PepGen
PEPG
$197M
$333K 0.01%
300,000
-1,360,932
-82% -$1.92M
SRPT icon
94
Sarepta Therapeutics
SRPT
$1.77B
$306K 0.01%
17,888
ZBH icon
95
Zimmer Biomet
ZBH
$18.4B
$297K 0.01%
3,260
PACS icon
96
PACS Group
PACS
$7.67B
$258K 0.01%
20,000
BAX icon
97
Baxter International
BAX
$14.2B
$241K 0.01%
7,970
ALGN icon
98
Align Technology
ALGN
$12.3B
$208K 0.01%
+1,100
New +$194K
ALNY icon
99
Alnylam Pharmaceuticals
ALNY
$29.3B
-9,370
Closed -$2.53M
CMG icon
100
Chipotle Mexican Grill
CMG
$41.5B
-539,540
Closed -$27.1M

Similar funds

Suvretta Capital Management's Q2 2025 Portfolio in Review

As of Q2 2025, Suvretta Capital Management held 112 positions worth $3.32B, up 23% from $2.69B the previous quarter. Its ten largest holdings account for 46% of the portfolio.

Suvretta Capital Management deployed $387M of net new capital in Q2 2025, opening 12 new positions and adding to 30 existing holdings. Its largest new stake was Dick's Sporting Goods: 260,465 shares worth $51.5M.

By sector, the portfolio is most concentrated in Healthcare at 49% of assets, down from 60% a quarter earlier, followed by Technology and Consumer Discretionary.

On the sell side, the largest reduction was Insmed, an estimated $95.9M trimmed.

  • Suvretta Capital Management's largest Q2 2025 buy was Dick's Sporting Goods: 260,465 shares worth $51.5M.
  • Suvretta Capital Management added most to Coca-Cola in Q2 2025, an estimated $58.2M increase.
  • Suvretta Capital Management's biggest Q2 2025 reduction was Insmed, cutting an estimated $95.9M.
  • Suvretta Capital Management fully exited Intra-Cellular Therapies Inc. in Q2 2025, selling an estimated $92.5M.
  • Suvretta Capital Management's ten largest holdings make up 46% of its $3.32B portfolio in Q2 2025.
  • Suvretta Capital Management opened 12 new positions and closed 14 in Q2 2025.
  • Suvretta Capital Management's portfolio value rose 23% quarter-over-quarter to $3.32B.

Based on Suvretta Capital Management's 13F filing for Q2 2025, filed 14 Aug 2025.